Following ketamine treatment, the cleavage of pro‐BDNF in the hippocampus significantly increased, suggesting that pro‐BDNF is related to the occurrence of depression and may be an indicator of antidepressant efficacy [98]. This evidence concerns the gene BDNF and major depressive disorder.